APA (7th ed.) Citation

N, F., M, H., W, S., M, H., M, W., T, T., . . . M, N. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosis. Annals of the rheumatic diseases, 78(6), 807. https://doi.org/10.1136/annrheumdis-2018-214764

Chicago Style (17th ed.) Citation

N, Ferdowsi, et al. "Development and Validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A Novel Instrument to Quantify Organ Damage in Systemic Sclerosis." Annals of the Rheumatic Diseases 78, no. 6 (2019): 807. https://doi.org/10.1136/annrheumdis-2018-214764.

MLA (9th ed.) Citation

N, Ferdowsi, et al. "Development and Validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A Novel Instrument to Quantify Organ Damage in Systemic Sclerosis." Annals of the Rheumatic Diseases, vol. 78, no. 6, 2019, p. 807, https://doi.org/10.1136/annrheumdis-2018-214764.